Edwards Lifesciences (EW) EBIT Margin (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly EBIT Margin of 28.97% for Q1 2026, up 102.0% year-over-year from 14.34% in Q1 2025, and up 200.94% quarter-over-quarter from 9.63% in Q4 2025.
Edwards Lifesciences (EW) EBIT Margin (2009 - 2026) Analysis & Trends
Edwards Lifesciences' EBIT Margin history runs 18 years deep, the most recent figure standing at 28.97% for Q1 2026.
- In Q1 2026, EBIT Margin rose 102.0% year-over-year to 28.97%; the TTM figure through Mar 2026 stood at 21.37% (down 443.0% YoY), while the FY2025 annual figure was 20.84%, down 451.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 28.97%, up from 9.63% in the prior quarter.
- The five-year high for EBIT Margin was 45.99% in Q4 2022, with the low at 9.63% in Q4 2025.
- The 5-year median for EBIT Margin is 27.38% (2023), against an average of 27.44%.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin jumped 1783 bps in 2022, then tumbled 1860 bps in 2023.
- Edwards Lifesciences' EBIT Margin stood at 45.99% in 2022, then sank by 40 bps to 27.38% in 2023, then declined by 18 bps to 22.56% in 2024, then slumped by 57 bps to 9.63% in 2025, then jumped by 201 bps to 28.97% in 2026.
- Business Quant data shows EW's EBIT Margin at 28.97% in Q1 2026, 9.63% in Q4 2025, and 19.77% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.48% |
| Mar 31, 2026 | 28.97% |
| Dec 31, 2025 | 9.63% |
| Sep 30, 2025 | 19.77% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 27.95% |
| Dec 31, 2024 | 22.56% |
| Sep 30, 2024 | 25.89% |
| Jun 30, 2024 | 26.76% |
| Mar 31, 2024 | 26.24% |
| Dec 31, 2023 | 27.38% |
| Sep 30, 2023 | 29.43% |
| Jun 30, 2023 | 20.60% |
| Mar 31, 2023 | 31.80% |
| Dec 31, 2022 | 45.99% |
| Sep 30, 2022 | 30.51% |
| Jun 30, 2022 | 33.44% |
| Mar 31, 2022 | 32.72% |
| Dec 31, 2021 | 28.16% |
| Sep 30, 2021 | 29.79% |